Navigation Links
ZYTO Corp. Appoints New Chief Operations Officer and New Chief Financial Officer
Date:1/24/2008

OREM, Utah, Jan. 24 /PRNewswire-FirstCall/ -- ZYTO Corp. (Pink Sheets: ZYTC) has announced the appointment of Lee Houghton as senior vice president and C.O.O., and Kami Howard as C.F.O.

The internal appointments come as part of the growth strategy planned for 2008, according to Dr. Vaughn R. Cook, company founder, president and C.E.O. Howard was previously in the position of C.O.O. and handled the financial responsibilities.

Howard joined ZYTO in April of 2007. She previously spent five years at Browz, LLC as a vice president and corporate controller. Prior to that she held a similar executive position with BioMeridian Corporation.

Houghton was previously vice president of manufacturing and quality assurance prior to this advancement. He came to ZYTO from the commercial real estate industry in the spring of 2007, and prior to that spent 16 years in the cabinet manufacturing industry.

ZYTO (TM) technology is used by doctors and health care providers to make decisions about the health care needs of their clients and patients. The company offers information at http://www.ZYTO.com.

There have been well over 100,000 clinical health assessments performed by health care professionals using ZYTO technology. The accuracy of the results and science that supports it has impressed the many practitioners who use it in their practice on a daily basis.

Dr. Lee Kinney, D.C. of Kinney Optimum Health & Wellness in Placerville, Calif. is typical of the many health care professionals who use ZYTO technology. "I use ZYTO technology in my practice to quickly and easily obtain a full health assessment which I can use to select just the right supplements that will give optimum function and well-being to my patients," he explained.

About ZYTO Corp.

ZYTO Corp. is a biotechnology company that uses quantum science to enable computers to communicate with the human body and mind. ZYTO t
'/>"/>

SOURCE ZYTO Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. LogistiCare, a Subsidiary of Providence Service Corp., Opens Phoenix Call Center to Support Expanding Commercial Client Base
2. Sharps Compliance Corp. Announces New Senior Vice President of Sales and Marketing
3. HMS Holdings Corp. to Present at 26th Annual JPMorgan Healthcare Conference
4. CDI-Life Sciences Selected by CJ CheilJedang Corp. to Provide Engineering Design for Major Pharmaceutical Complex in Korea
5. New Health Corp. Introduces Heart Savior(TM), the Ultimate Natural Heart Health Product
6. CIG Corp. Establishes a Medical Advisory Board
7. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
8. Stryker Corp. & Physiotherapy Associates to Pay U.S. $16.6 Million for Alleged False Claims to Federal Health Care Programs
9. ThermoGenesis Corp. Reports First Quarter 2008 Results
10. AXIOM Selects Foresight Corp. for Integration Partnership
11. Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewswire/ ...essional cycling team dedicated to ethical sportin...ampions, announced today that it will become Team ...s Optical as a new sponsor of the team. Transition...daptive eyewear, offering the most advanced photoc...
(Date:11/27/2009)... XenaCare Holdings has announced that... Foundation, one of the largest nonprofit organiza...ealth education. , Delray...oldings, Inc. (OTCBB: XCHO), a company specializin...umer healthcare products, has announced today that...
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...r and sanitation severely limited in Lebanon due t...ncies have stepped up preparations for a coordinat...ess to health care for injured and patients with c...h attacks on July 12. WHO said it is assistin...
...t after memory begins to decline, executive functi...e progression from mild cognitive// impairment, a ...disease. Ron Petersen, M.D., Ph.D., Mayo Cli... "If someone with mild cognitive impairment start...
...ases the risk of hospitalization and death from he... absence of established// risk factors, says a stu... Association. An assistant professor of pre... in early life with hospitalization and subsequent...
... going by the current trends tobacco will probably...e almost 10 times the toll// it took in the 20th c...r of the American Cancer Society said, "In all of ...ncer, 1 in 5 death due to cancer is due to tobacco...
...hout Africa could help to avert about 5,7-million ... that was published in Public Library of Science M... 300 000 deaths and about two million new infectio... circumcision reduces male vulnerability to HIV in...
...ve birth to triplets through IVF procedure three y...ut any infertility treatments. She gave birth to t... because they're healthy and so am I," Magdaleno s...'m happy but, I don't know. I don't know how to ex...
Other Medicine News:Health News:Decline in Concentration, Decision-Making and Problem-Solving 2Health News:Tobacco Epidemic On The Rise 2Health News:Circumcision to Avert HIV Infection 2
(Date:11/27/2009)...Minn, Nov. 27 ACUO TECHNOLOGIES, d...ment software, data migration tools and services, ...nt and Trademark Office has approved a patent appl...a Computer Network." Acuo Technologies is pleased ...ctual property. In general, the granted patent app...
(Date:11/26/2009)...BURG, South Africa, Nov. 26 The 20...e Year Award in the Generic Pharmaceutical Market ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh...ar Award, the following criteria were used to benc...titors: growth strategy and implementation, degree...
(Date:11/25/2009)...Fla., Nov. 25 American...he Company") is pleased to announce that they have...ment office in Shanghai, China. ,, ASR has been...sential gateway for the development and production...for children and adults to be distributed and sold...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4American Scientific Resources Inc. Opens Shanghai Location 2Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 1Sagent Pharmaceuticals Announces Launch of Adenosine Injection USP in 6 mg per 2 mL Single Dose Vials 4930 2Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 1American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 2American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles 55852 3
...entative medicine doctors say they are outraged,ov...rescribing,human growth hormone to treat a hormone...BEACH, Fla., April 27, 2007 /PRNewswire/ -- The ad...enter of a recent New,York Times article about the...dicine (<a target="_blank" href=,"http://worldheal...
...: 0in 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",a...ab-stops: list .5in; mso-list: l1 level1 lfo2">, <...othic MT,; mso-bidi-font-weight: bold">,Independen... adding,Diovan to conventional therapy , , , ,<...in; mso-list: l1 level1 lfo2">, <span style=,"FONT...
Other Medicine Technology:Doctors Outraged Over Growth Hormone Controversy 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
Blue Line® Intubation Stylet 7.5 mm 10 mm
Lighted Pediatric Stylet - Non-Sterile
Surch-Lite™ Flexible Light - 15" Non-Sterile
Peripheral Nerve Stimulator Electrodes
Medicine Products: